It's described as the biggest initial offering ever for a biotech in the preclinical stage, meaning it has no products in clinical trials yet.
source https://www.seattletimes.com/business/seattle-startup-sana-biotech-prices-big-stock-offering/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_technology
No comments:
Post a Comment